Replies to post #214462 on Biotech Values

[ciotera]

Re: CELG
Possibly, over its entire life-cycle.
I have not seen the forecasts, but this was one treatment that could get ahead of the TNFs (even biosimilar TNFs), so there were a lot of high hopes attached to it. Like with JAKs at some point (and still to some extent).